XML 55 R5.htm IDEA: XBRL DOCUMENT v3.20.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Public offering
At-the-market
2018 Stock purchase agreement
2019 Stock purchase agreement
Common Stock
Common Stock
Public offering
Common Stock
At-the-market
Common Stock
2018 Stock purchase agreement
Common Stock
2019 Stock purchase agreement
Additional Paid-in Capital
Additional Paid-in Capital
Public offering
Additional Paid-in Capital
At-the-market
Additional Paid-in Capital
2018 Stock purchase agreement
Additional Paid-in Capital
2019 Stock purchase agreement
Accumulated Other Comprehensive Gain (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2017           22,568,006                      
Beginning balance at Dec. 31, 2017 $ 38,510         $ 226         $ 131,877         $ 0 $ (93,593)
Stockholders’ deficit                                  
Issuance of common stock, net of issuance cost (in shares)             7,414,996 372,852 150,987                
Issuance of common stock, net of issuance cost   $ 37,845 $ 2,657 $ 935     $ 74 $ 4 $ 2     $ 37,771 $ 2,653 $ 933      
Shares issued for cash upon the exercise of stock options (in shares)           280,178                      
Shares issued for cash upon the exercise of stock options 182         $ 2         180            
Issuance of common stock for cash under employee stock purchase plan (in shares)           52,444                      
Issuance of common stock for cash under employee stock purchase plan 242                   242            
Share-based compensation expense 3,679                   3,679            
Change in unrealized gain on investments (3)                             (3)  
Net loss $ (32,703)                               (32,703)
Ending balance (in shares) at Dec. 31, 2018 30,839,463         30,839,463                      
Ending balance at Dec. 31, 2018 $ 51,344         $ 308         177,335         (3) (126,296)
Stockholders’ deficit                                  
Issuance of common stock, net of issuance cost (in shares)               658,000 606,364 2,557,544              
Issuance of common stock, net of issuance cost     $ 758 $ 483 $ 890     $ 7 $ 6 $ 26     $ 751 $ 477 $ 864    
Shares issued for cash upon the exercise of stock options (in shares)           144,252                      
Shares issued for cash upon the exercise of stock options 87         $ 1         86            
Issuance of common stock for cash under employee stock purchase plan (in shares)           56,253                      
Issuance of common stock for cash under employee stock purchase plan 110         $ 1         109            
Share-based compensation expense 3,970                   3,970            
Reclassification of warrant liability from equity (18)                   (18)            
Change in unrealized gain on investments 3                             3  
Net loss $ (41,873)                               (41,873)
Ending balance (in shares) at Dec. 31, 2019 34,861,876         34,861,876                      
Ending balance at Dec. 31, 2019 $ 15,754         $ 349         $ 183,574         $ 0 $ (168,169)